Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Monday. The firm issued a hold rating on the stock.

Retractable Technologies Price Performance

Shares of RVP opened at $0.75 on Monday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The stock has a market cap of $22.32 million, a P/E ratio of -1.38 and a beta of 1.94. The stock’s 50-day moving average price is $0.66 and its two-hundred day moving average price is $0.86. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.34.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.